IP Library › Assignment 050478/0695
Patent Assignment
Reel/Frame 050478/0695

Release of Security Interest

Recorded: 2019-09-24 Pages: 5
Assignor
NOVELION THERAPEUTICS INC.
Executed: 2019-09-24
Assignee
AEGERION PHARMACEUTICALS, INC.
ONE MAIN STREET, SUITE 800, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties (3)
Compound Impurities and Methods of Detecting Same
Application: 15/570,246 →
Publication: US 2018/0133205
Methods of Detecting Anti-Leptin Neutralizing Antibodies
Application: 15/702,719 →
Publication: US 2018/0074073
Engineered Polypeptides Having Enhanced Duration of Action and Reduced Immunogenicity
Application: 15/882,919 →
Publication: US 2018/0305430
Related Assignments (10)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest Nov 8, 2018
From: AEGERION PHARMACEUTICALS, INC.
To: CANTOR FITZGERALD SECURITIES, AS ADMINISTRATIVE AGENT
Reel/Frame 047447/0926 →
Patent Security Agreement Nov 8, 2018
From: AEGERION PHARMACEUTICALS, INC.
To: NOVELION THERAPEUTICS INC.
Reel/Frame 047455/0385 →
Assignment of Assignor's Interest Jan 20, 2019
From: GELORMINI, ANN
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 048064/0178 →
Security Interest Sep 24, 2019
From: AEGERION PHARMACEUTICALS, INC.
To: CANTOR FITZGERALD SECURITIES, AS ADMINISTRATIVE AGENT
Reel/Frame 050478/0204 →
Release of Security Interest Sep 24, 2019
From: CANTOR FITZGERALD SECURITIES, AS ADMINISTRATIVE AGENT
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 050478/0629 →
Assignment of Assignor's Interest May 6, 2020
From: SAILSTAD, JEFFREY
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 052590/0679 →
Change of Name May 10, 2021
From: AEGERION PHARMACEUTICALS, INC.
To: AMRYT PHARMACEUTICALS, INC.
Reel/Frame 056193/0437 →
Security Interest Feb 18, 2022
From: AMRYT PHARMACEUTICALS, INC.
To: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 059049/0164 →
Release of Security Interest Feb 23, 2022
From: CANTOR FITZGERALD SECURITIES, AS ADMINISTRATIVE AGENT
To: AEGERION PHARMACEUTICALS, INC.; AMRYT RESEARCH LIMITED
Reel/Frame 059074/0604 →
Release of Security Interest Apr 13, 2023
From: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: AMRYT GENETICS LIMITED; AMRYT PHARMACEUTICALS, INC.; AMRYT ENDO, INC.; AMRYT RESEARCH LIMITED
Reel/Frame 063318/0849 →